Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07344636

Effects of NR Supplementation on Metabolic Flexibility in Zone 2 Training

Zone 2 training, a low-intensity endurance exercise performed at approximately 66-80% of VO₂max or near the first ventilatory threshold, has gained popularity for improving aerobic capacity, fat metabolism, and mitochondrial efficiency. It preserves glycogen stores and delays fatigue, making it an essential training method for both athletes and recreational exercisers. Nicotinamide adenine dinucleotide (NAD) is a vital metabolite that regulates cellular energy metabolism and redox homeostasis. It participates in oxidative reactions within the tricarboxylic acid cycle and electron transport chain, sustaining ATP synthesis and mitochondrial efficiency. Exercise influences multiple pathways of NAD metabolism, altering the NAD⁺/NADH ratio and thereby affecting energy production and fatigue resistance. Studies have shown that both aerobic exercise and NAD precursor supplementation (e.g., nicotinamide riboside [NR]) can elevate body NAD levels and enhance mitochondrial function, though findings remain inconsistent due to variations in dosage and participants' characteristics. This study aims to investigate how acute NR supplementation interacts with Zone 2 cycling training in adults. Specifically, it examines the temporal and dose-dependent effects of NR supplementation on metabolic flexibility and exercise performance. The results may clarify the potential synergistic benefits of combining NAD supplementation with low-intensity endurance training to improve aerobic adaptability.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

G02, Kwok Sports Building, The Chinese University of Hong Kong

Hong Kong, Please Select, 999077, China

Location status: Recruiting

Location contact

Jiaqi ZHANG

CONTACT

[email protected]

852 95596303

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Over 18 years old
  • BMI <30 kg/m2

Exclusion criteria

  • Present of health conditions that contraindicate participation in exercise training, such as a history of cardiovascular disease, cancer, or musculoskeletal disorders
  • Currently taking vitamin B supplements and/or NAD precursors
  • Taking medication that may affect the test results

Treatment and study plan

Nicotinamide Riboside (NR)

Dietary Supplement

600 mg NR

Primary outcomes

  1. Substrate utilization (CHO and fat oxidation rate)

    Time frame: From enrollment to the end of treatment at 4 weeks

Secondary outcomes

  1. Oxygen consumption

    Time frame: From enrollment to the end of treatment at 4 weeks

  2. Heart rate

    Time frame: From enrollment to the end of treatment at 4 weeks

  3. Blood glucose concentration

    Time frame: From enrollment to the end of treatment at 4 weeks

  4. Blood lactate concentration

    Time frame: From enrollment to the end of treatment at 4 weeks

  5. Peak power output

    Time frame: From enrollment to the end of treatment at 4 weeks

  6. Mean power output

    Time frame: From enrollment to the end of treatment at 4 weeks

  7. Rating of perceived exertion

    Time frame: From enrollment to the end of treatment at 4 weeks

  8. Muscle pain scale

    Time frame: From enrollment to the end of treatment at 4 weeks

    Muscle pain scale is a 5-point likert scale ranging from "1- Not at all" to "5- Extreme", with higher value indicating muscle pain.

  9. Muscle fatigue scale

    Time frame: From enrollment to the end of treatment at 4 weeks

    Muscle fatigue scale is a 5-point likert scale ranging from "1- Not at all" to "5- Extreme", with higher value indicating muscle fatigue.

Other outcomes

  1. Height

    Time frame: From enrollment to the end of treatment at 4 weeks

  2. Weight

    Time frame: From enrollment to the end of treatment at 4 weeks

  3. Power output at VT1

    Time frame: From enrollment to the end of treatment at 4 weeks

  4. Health history questionnaire

    Time frame: From enrollment to the end of treatment at 4 weeks

    This questionnaire includes questions regarding participant's present/past history of diseases and his/her family history of diseases.

  5. International Physical Activity Questionnaire (IPAQ)

    Time frame: From enrollment to the end of treatment at 4 weeks

    IPAQ is a validated questionnaire to measure the physical activity of participants during the past 7 days. The score will be transformed to metabolic equivalents of tasks per week (METs/week), with higher value indicating greater participation in physical activity.

Sponsors and collaborators

Lead sponsor

ZHANG Jiaqi

Other

Registry information

Official study title

Temporal and Dose-response Effects of Nicotinamide Riboside Supplementation on Metabolic Flexibility During Zone 2 Training in Adults: a Double-blinded, Randomized, Controlled, Crossover Trial

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jan 15, 2026
Registry last updated
Mar 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.